Evidence map›Paper›PMID 32193264›Full record

ArticleBMJ open2020

Influence of combined vitamin D

Anneka Elizabeth Welford, Susan Lanham-New, Janet Lord, Alison Doyle, Julie Robinson, Peter Nightingale, Neil Gittoes, Carolyn A Greig

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Anneka Elizabeth WelfordSchool of Sports, Exericse and Rehabilitation Sciences, University of Birmingham, Birmingham, UK aea423@bham.ac.uk.ORCID 0000-0003-3305-6492
Susan Lanham-NewDepartment of Nutritional Sciences, University of Surrey, Surrey, UK.
Janet LordMRC-Arthritis UK Centre for Musculoskeletal Ageing Research, University of Birmingham, Birmingham, West Midlands, UK.
Alison DoyleThe Royal Osteoporosis Society, Bath, UK.
Julie RobinsonMove it or Lose it, Birmingham, UK.
Peter NightingaleWellcome Trust Clinical Research Facility, Queen Elizabeth Hospital Birmingham, Birmingham, West Midlands, UK.
Neil GittoesCentre for Endocrinology, Diabetes and Metabolism, Queen Elizabeth Hospital Birmingham, Birmingham, Birmingham, UK.
Carolyn A GreigMRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, MRC-Arthritis Research UK Centre for Musculoskeletal Ageing Research, Birmingham, UK.
University of Birmingham · GBArthritis UK · GBQueen Elizabeth Hospital Birmingham · GBRoyal Osteoporosis Society · GBUniversity Hospitals Birmingham NHS Foundation Trust · GBUniversity of Surrey · GB

Funding

Medical Research Council MR/K00414X/1Medical Research Council MR/P021220/1Wellcome Trust
6 · The paper itself

Abstract

introductionSarcopenia is a progressive loss in muscle mass, strength and function, the adverse consequences of which are severe, affecting quality of life and placing an increasing burden on social and healthcare systems. Vitamin D status is known to be associated with markers of sarcopenia, namely muscle mass, strength and function. Also, resistance exercise training (RET) is currently the only proven intervention to treat sarcopenia. However, very little data exist on the influence of combining the two interventions of vitamin D supplementation and resistance exercise training, although a recent systematic review provides tentative support for the current study's hypothesis that the combined intervention may further improve musculoskeletal function above exercise training alone. The aim of the present study is to determine whether vitamin D METHODS AND ANALYSIS: This double-blinded randomised placebo-controlled trial will recruit a target of 127 eligible men and women aged ≥65 years living independently or in sheltered housing within the Birmingham area to two groups: (1) 6 months RET and placebo or (2) 6 months RET and 800 IU/d vitamin D ETHICS AND DISSEMINATION: The EXVITD study has ethical approval granted by the Black Country National Health Service Research Ethics Committee (14/WM/1220). Results of this trial will be submitted for publication in peer-reviewed journals and presented at conferences. The study is being conducted according to the principles of the Declaration of Helsinki.

Indexed as

Dietary SupplementsMusculoskeletal SystemResistance TrainingAgedCholecalciferolFemaleHumansMaleMuscle StrengthQuality of LifeRandomized Controlled Trials as TopicCholecalciferolBMDmuscle strengthmusculoskeletal healtholder adultsRandomised controlled trialvitamin D

Identifiers

PMID32193264
PMCPMC7202733
OpenAlexW3010884604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.